CVS HEALTH Corp - 8-K Filing
CVS Health Corporation held its 2026 Annual Meeting of Stockholders on May 14, 2026, where the stockholders approved the 2026 Incentive Compensation Plan (replacing the expiring 2017 plan), ratified Ernst & Young LLP as independent auditors for 2026, and approved advisory votes on executive compensation. The company also elected its board of directors with all 13 nominees receiving majority support; however, a stockholder proposal to reduce the threshold for written consent was not approved. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $CVS